IsoPet® Blog

Certified IsoPet® Treatment Centers are expanding across the USA to offer our safe and effective cancer treatment.

Vivos Inc Summarizes Progress in its Animal Therapy Division

December 23, 2025

The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.

To Read the full Press Release, please visit:
https://www.globenewswire.com/news-release/2025/12/22/3209481/0/en/Vivos-Inc-Summarizes-Progress-in-its-Animal-Therapy-Division.html

About the Author:

Michael Korenko

Dr. Michael Korenko has a Doctor of Science from MIT, was a NATO Postdoctoral Fellow at Oxford University, and was selected as a White House Fellow for the Department of Defense. Dr. Korenko currently is the author of 28 patents and possesses extensive experience in nuclear applications. He is leading the Vivos Inc. team into treating cancer in animals and humans.

Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

Safe & Effective

IsoPet® delivers more than 90% of its therapeutic radiation within 10 days of a single treatment. Other therapies may require six weeks or more to deliver the full course.

Same Day Procedure

IsoPet® therapy is performed as an out-patient procedure and your pet may return home without subsequent concern for radiation exposure to your pet or family.

Minimal Side Effects

IsoPet® therapy is administered directly into the tumor without harm to the surrounding tissues or organs. Your pet will not feel any side effects of treatment.